Related Experiment Video
Updated: Feb 7, 2026

Evaluation of Substrate Ubiquitylation by E3 Ubiquitin-ligase in Mammalian Cell Lysates
Published on: May 10, 2022
R1 Regulates Prostate Tumor Growth and Progression By Transcriptional Suppression of the E3 Ligase HUWE1 to Stabilize
Tzu-Ping Lin1,2,3,4, Jingjing Li5, Qinlong Li6,7
1Depatment of Pharmacology and Pharmaceutical Sciences, School of Pharmacy, University of Southern California, Los Angeles, California.
Abstract:
Prostate cancer is a prevalent public health problem, especially because noncutaneous advanced malignant forms significantly affect the lifespan and quality of life of men worldwide. New therapeutic targets and approaches are urgently needed. The current study reports elevated expression of R1 (CDCA7L/RAM2/JPO2), a c-Myc-interacting protein and transcription factor, in human prostate cancer tissue specimens. In a clinical cohort, high R1 expression is associated with disease recurrence and decreased patient survival. Overexpression and knockdown of R1 in human prostate cancer cells indicate that R1 induces cell proliferation and colony formation. Moreover, silencing R1 dramatically reduces the growth of prostate tumor xenografts in mice. Mechanistically, R1 increases c-Myc protein stability by inhibiting ubiquitination and proteolysis through transcriptional suppression of HUWE1, a c-Myc-targeting E3 ligase, via direct interaction with a binding element in the promoter. Moreover, transcriptional repression is supported by a negative coexpression correlation between R1 and HUWE1 in a prostate cancer clinical dataset. Collectively, these findings, for the first time, characterize the contribution of R1 to prostate cancer pathogenesis. IMPLICATIONS: These findings provide evidence that R1 is a novel regulator of prostate tumor growth by stabilizing c-Myc protein, meriting further investigation of its therapeutic and prognostic potential.
Insights
Researchers discovered that elevated R1 protein levels in prostate cancer correlate with worse outcomes. R1 (CDCA7L) promotes tumor growth by stabilizing the c-Myc oncoprotein, suggesting R1 as a potential therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Prostate cancer poses a significant global health challenge, necessitating novel therapeutic strategies.
- Identifying new molecular targets is crucial for improving patient outcomes and quality of life.
Purpose of the Study:
- To investigate the role of R1 (CDCA7L), a c-Myc-interacting protein, in prostate cancer pathogenesis.
- To explore R1 as a potential therapeutic and prognostic marker for prostate cancer.
Main Methods:
- Analysis of R1 expression in human prostate cancer tissues and correlation with clinical data.
- In vitro studies involving R1 overexpression and knockdown in prostate cancer cell lines.
- In vivo experiments using prostate tumor xenografts in mice.
- Mechanistic studies to elucidate R1's effect on c-Myc stability and HUWE1 expression.
Main Results:
- R1 expression is elevated in prostate cancer tissues and associated with disease recurrence and reduced patient survival.
- R1 overexpression enhances prostate cancer cell proliferation and colony formation.
- Silencing R1 significantly inhibits prostate tumor xenograft growth in mice.
- R1 stabilizes c-Myc by transcriptionally suppressing HUWE1, a c-Myc-targeting E3 ligase.
Conclusions:
- R1 is a novel regulator of prostate tumor growth, acting by increasing c-Myc protein stability.
- These findings highlight R1's potential as a therapeutic target and prognostic biomarker in prostate cancer.
- Further research into R1's therapeutic and prognostic potential is warranted.
Related Concept Videos
Master Transcription Regulators
Master Transcription Regulators
Cooperative Binding of Transcription Regulators
Cooperative Binding of Transcription Regulators
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

